Drug Shortage Report for ONDANSETRON INJECTION USP

Last updated on 2022-04-09 History
Report ID 155955
Drug Identification Number 02464578
Brand name ONDANSETRON INJECTION USP
Common or Proper name ONDANSETRON INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) ONDANSETRON
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS 4 ML
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2022-02-03
Estimated end date Unknown
Actual end date 2022-04-08
Shortage status Resolved
Updated date 2022-04-09
Company comments Limited quantities remaining at McKesson. All hospital contracts have been covered by other Marketing Authorization holders.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-04-09 English Compare
v4 2022-04-07 French Compare
v3 2022-04-07 English Compare
v2 2022-03-03 French Compare
v1 2022-03-03 English Compare

Showing 1 to 5 of 5